peoplePerson
Carsten Bokemeyer
Medical oncologist known for germ cell tumour research and anti-EGFR trials in colorectal cancer.
Carsten Bokemeyer directs oncology at UKE Hamburg and led the OPUS trial of cetuximab with FOLFOX in colorectal cancer alongside a long record in germ cell tumours.
Role
Director, Department of Oncology, Hematology and BMT, UKE Hamburg
Institution
Specialisms
Testicular cancerColorectal cancerMedical oncology
Profiles
Pages like this
not linked directly; found by shared links- PersonDongsheng Tu
Shares Cetuximab, Colorectal cancer.
- PersonVolker Heinemann
Shares Cetuximab, Colorectal cancer.
- PersonRyan B. Corcoran
Shares Cetuximab, Colorectal cancer.
- PersonJosep Tabernero
Shares Cetuximab, Colorectal cancer.
- PairingAnti-EGFR antibody + chemotherapy in left-sided RAS/BRAF wild-type mCRC
Shares Cetuximab, Colorectal cancer.
- TrialCRYSTAL & FIRE-3
Shares Cetuximab, Colorectal cancer.
- TrialBREAKWATER
Shares Cetuximab, Colorectal cancer.
- CompanyEli Lilly (incl. Loxo)
Shares Cetuximab, Colorectal cancer.